By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse scarring of the ...

The policies of President Donald Trump will fail to hold back progress in transitioning away from high-carbon energy sources, according to analysts at Citigroup Inc.